Market revenue in 2023 | USD 169.3 million |
Market revenue in 2030 | USD 204.1 million |
Growth rate | 2.7% (CAGR from 2023 to 2030) |
Largest segment | Cannabis/marijuana |
Fastest growing segment | Cannabis/Marijuana |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug of abuse testing services market will help companies and investors design strategic landscapes.
Cannabis/marijuana was the largest segment with a revenue share of 24.28% in 2023. Horizon Databook has segmented the India drug of abuse testing services market based on alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, lsd, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
According to a report published by the Ministry of Social Justice and Empowerment, Government of India, in 2019, alcohol was the most common substance used in India; about 14.6% of the Indian population consumed alcohol. Opioids and cannabis are the next commonly used substances in India. About 2.8% of the population, or 31 million individuals, consume opioids and cannabis in India.
Other categories of drugs such as amphetamine-type stimulants (0.18%), cocaine (0.10%), and hallucinogens (0.12%) are used by a very small proportion. In addition, the nationwide lockdown due to the ongoing COVID-19 pandemic has led to a higher number of drug abuse cases. It is anticipated to significantly boost the demand for the drug of abuse testing services in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the India drug of abuse testing services market , including forecasts for subscribers. This country databook contains high-level insights into India drug of abuse testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account